Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-23-012103

Director acquired 12,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2023-02-06 Option exercise +12,000 $2.65 $31,800 142,046 D
Derivatives
Kraus Al Director 2023-02-06 Option exercise · Stock Option (right to buy) −12,000 0 D
Loading xslF345X03/tm235846-1_4seq1.xml…